171 related articles for article (PubMed ID: 28196426)
1. Development of a Functional Observational Battery in the Minipig for Regulatory Neurotoxicity Assessments.
Zhong M; Shoemake C; Fuller A; White D; Hanks C; Brocksmith D; Liu J; Gad S; Bouchard G; Stricker-Krongrad A
Int J Toxicol; 2017; 36(2):113-123. PubMed ID: 28196426
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neurotoxicity potential in rats: the functional observational battery.
Boucard A; Bétat AM; Forster R; Simonnard A; Froget G
Curr Protoc Pharmacol; 2010 Dec; Chapter 10():Unit 10.12. PubMed ID: 21935896
[TBL] [Abstract][Full Text] [Related]
3. Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice.
Lai CC; Lee LJ; Yin HS
Neurotoxicology; 2013 Jul; 37():136-43. PubMed ID: 23660488
[TBL] [Abstract][Full Text] [Related]
4. A functional observational battery in non-human primates for regulatory-required neurobehavioral assessments.
Gauvin DV; Baird TJ
J Pharmacol Toxicol Methods; 2008; 58(2):88-93. PubMed ID: 18586529
[TBL] [Abstract][Full Text] [Related]
5. CNS Safety Screening Under ICH S7A Guidelines Requires Observations of Multiple Behavioral Units to Assess Motor Function.
Gauvin DV; Zimmermann ZJ; Dalton JA; Baird TJ; Kallman MJ
Int J Toxicol; 2019; 38(5):339-356. PubMed ID: 31470748
[TBL] [Abstract][Full Text] [Related]
6. The functional observational battery and modified Irwin test as global neurobehavioral assessments in the rat: Pharmacological validation data and a comparison of methods.
Redfern WS; Dymond A; Strang I; Storey S; Grant C; Marks L; Barnard C; Heys C; Moyser K; Greenwood K; Cobey D; Moore N; Karp NA; Prior H
J Pharmacol Toxicol Methods; 2019; 98():106591. PubMed ID: 31146025
[TBL] [Abstract][Full Text] [Related]
7. The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Colleton C; Brewster D; Chester A; Clarke DO; Heining P; Olaharski A; Graziano M
Toxicol Pathol; 2016 Apr; 44(3):458-66. PubMed ID: 27006130
[TBL] [Abstract][Full Text] [Related]
8. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.
Descotes J; Allais L; Ancian P; Pedersen HD; Friry-Santini C; Iglesias A; Rubic-Schneider T; Skaggs H; Vestbjerg P
Regul Toxicol Pharmacol; 2018 Apr; 94():271-275. PubMed ID: 29481836
[TBL] [Abstract][Full Text] [Related]
9. Nervous System Sampling for General Toxicity and Neurotoxicity Studies in the Laboratory Minipig With Emphasis on the Göttingen Minipig.
Pardo ID; Manno RA; Capobianco R; Sargeant AM; Morrison JP; Bolon B; Garman RH
Toxicol Pathol; 2021 Aug; 49(6):1140-1163. PubMed ID: 34423710
[TBL] [Abstract][Full Text] [Related]
10. Differential behavioral profiling of stimulant substances in the rat using the LABORAS™ system.
Castagné V; Wolinsky T; Quinn L; Virley D
Pharmacol Biochem Behav; 2012 Jun; 101(4):553-63. PubMed ID: 22425596
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
Leite JV; Guimarães FS; Moreira FA
Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
[TBL] [Abstract][Full Text] [Related]
12. Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.
Diester CM; Santos EJ; Moerke MJ; Negus SS
J Pharmacol Exp Ther; 2021 May; 377(2):232-241. PubMed ID: 33622770
[TBL] [Abstract][Full Text] [Related]
13. Combined Cardiopulmonary Assessments Using Impedance and Digital Implants in Conscious Freely Moving Cynomolgus Monkeys, Beagle Dogs, and Göttingen Minipigs: Pharmacological Characterization and Social Housing Effects.
Boulay E; Troncy E; Pugsley M; St-Pierre J; Downey AM; Smutova V; Guerrier M; Maghezzi S; Authier S
Int J Toxicol; 2021 Dec; 40(6):530-541. PubMed ID: 34610777
[TBL] [Abstract][Full Text] [Related]
14. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
Wang C; Slikker W
Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of standard nerve agent medical countermeasures in Göttingen Minipigs.
Langston JL; Moffett MC; Pennington MR; Myers TM
Toxicol Lett; 2024 Jun; 397():103-116. PubMed ID: 38703967
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of effects detected in the rat functional observational battery following oral administration of non-CNS targeted compounds.
Redfern WS; Strang I; Storey S; Heys C; Barnard C; Lawton K; Hammond TG; Valentin JP
J Pharmacol Toxicol Methods; 2005; 52(1):77-82. PubMed ID: 15936219
[TBL] [Abstract][Full Text] [Related]
17. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
Dunne F; O'Halloran A; Kelly JP
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
19. The Use of Minipig in Drug Discovery and Development: Pros and Cons of Minipig Selection and Strategies to Use as a Preferred Nonrodent Species.
Heining P; Ruysschaert T
Toxicol Pathol; 2016 Apr; 44(3):467-73. PubMed ID: 26674804
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and Electroretinographic Characterization of the Minipig Eye in the Context of Drug Safety Investigations.
Negro Silva LF; Li C; de Seadi Pereira PJB; Tan W; Dubuc-Mageau M; Sanfacon A; Forster R; Tavcar R; Makin A; Authier S
Int J Toxicol; 2019; 38(5):415-422. PubMed ID: 31470746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
